Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Accumulated Depreciation & Amortization (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Accumulated Depreciation & Amortization for 12 consecutive years, with $14.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 14.46% to $14.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $14.5 million, a 14.46% increase, with the full-year FY2024 number at $14.5 million, up 14.46% from a year prior.
  • Accumulated Depreciation & Amortization was $14.5 million for Q4 2024 at Usana Health Sciences, up from $12.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $14.5 million in Q4 2024 to a low of $12.7 million in Q4 2023.
  • A 4-year average of $13.5 million and a median of $13.4 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 84.05% in 2021, then rose 14.46% in 2024.
  • Usana Health Sciences' Accumulated Depreciation & Amortization stood at $13.7 million in 2021, then decreased by 2.58% to $13.4 million in 2022, then dropped by 5.16% to $12.7 million in 2023, then rose by 14.46% to $14.5 million in 2024.
  • Per Business Quant, the three most recent readings for USNA's Accumulated Depreciation & Amortization are $14.5 million (Q4 2024), $12.7 million (Q4 2023), and $13.4 million (Q4 2022).